Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Biochemical and Biophysical Research Communications|November 4, 2019
WWP2 regulates proliferation of gastric cancer cells in a PTEN-dependent mannerKe Wang, Jun Liu, Xinhui Zhao, et al.
Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban|November 1, 2011
Comparative study on the efficacy of tiotropium bromide inhalation and oral doxofylline treatment of moderate to severe stable chronic obstructive pulmonary diseaseTao Wang, Guangwei Luo, Yi Hu, et al.
Acta Ophthalmologica|December 30, 2018
Novel BEST1 mutations and special clinical characteristics of autosomal recessive bestrophinopathy in Chinese patientsJingyi Luo, Mingkai Lin, Xinxing Guo, et al.
Journal of Clinical Laboratory Analysis|May 10, 2021
Targeted resequencing showing novel common and rare genetic variants increases the risk of asthma in the Chinese Han populationJuan Liu, Yanhan Deng, Bo Yu, et al.
Signal Transduction and Targeted Therapy|December 3, 2024
Efficacy and safety of minocycline in retinitis pigmentosa: a prospective, open-label, single-arm trialYuxi Chen, Yuan Pan, Yanyan Xie, et al.
Journal of Clinical Laboratory Analysis|May 4, 2021
A nonsynonymous polymorphism (rs117179004, T392M) of hyaluronidase 1 (HYAL1) is associated with increased risk of idiopathic pulmonary fibrosis in Southern Han ChineseJuan Liu, Yanhan Deng, Zheng Wang, et al.
Trials|May 26, 2020
Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trialYeming Wang, Fei Zhou, Dingyu Zhang, et al.
Human Mutation|June 20, 2018
Targeted resequencing reveals genetic risks in patients with sporadic idiopathic pulmonary fibrosisYanhan Deng, Zongzhe Li, Juan Liu, et al.
Lancet (London, England)|May 20, 2020
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trialYeming Wang, Dingyu Zhang, Guanhua Du, et al.
Pageof 5